Topical calcipotriol in dermatology
Keywords:
Calcipotriol, dermatological disordersAbstract
Calcipotriol is a vitamin D analogue, which has antiproliferative and anti-inflammatory effects and stimulates terminal differentiation of keratinocytes by acting through immunologic mechanism and regulating intracellular calcium concentration. It is currently being used in many dermatoses e.g. psoriasis, vitiligo, morphoea, pityriasis rubra pilaris, ichthyoses and palmoplantar keratodermas. The present article reviews the therapeutic potential of topical calcipotriol in various dermatological disorders.ÂReferences
Brown AJ. Vitamin D analogues. Am J A Kid Dis 1998; 32 (Suppl 2): S25-39.
Gniadecki R. Influence of 1,25-dihydroxy vitamin D3 and vitamin D3 analogues on keratinocyte growth and differentiation. Acta Derm Venereol 1998; 202 (Suppl): 1-23.
Bertolini DL, Araujo PR, Silva RN. Immunomodulatory effects of vitamin D analogue KH1060 on an experimental skin transplantation model. Transplant Proc 1999; 31: 2998-9.
Elisabeth AH, Gregor BE. The therapeutic potential of calcipotriol in diseases other than psoriasis. Int J Dermatol 2002; 41: 38-43.
Kragballe K, Steijlen PM, Ibsen HH et al. Efficacy, tolerability and safety of calcipotriol ointment in disorders of keratinization. Results of a randomized, double blind, vehicle-controlled, right/left comparative study. Arch Dermatol 1993; 131: 556-60.
Parsad D, Saini R, Nagpal R. Calcipotriol in vitiligo: a preliminary study. Ped Dermatol 1999; 16: 317-20.
Schallreuter KU, Pittelkow MR. Defective calcium uptake in keratinocyte cell culture from vitiliginous skin. Arch Dermatol Res 1988; 280: 137-9.
Schallreuter KU Pittelkow MR, Swanson NN. Defective calcium transport in vitiliginous malanocytes. Arch Dermatol Res 1996; 228: 11-3.
Ameen M, Exarchou V, Chu AC. Topical calcipotriol as monotherapy and in combination with psoralen plus ultraviolet A in the treatment of vitiligo. Br J Dermatol 2001; 145: 476-9.
Kovacs SO. Vitiligo. J Am Acad Dermatol 1998; 38: 647-66.
Ashcroft DM, Po AL, Williams HC et al. Systemic review of comparative efficacy and tolerability of calcipotriol in treating chronic plaque psoriasis. Br Med J 2000; 320: 963-7.
Kumaran M, Kaur I, Kumar B. Effect of topical clacipotriol, betamethasone dipropronate and their combination in the treatment of localized vitiligo. J Eur Acad Dermatol Venereol 2006; 20: 269-73.
Lucker GP, Van de Kerkhof PC, Van Dijk MR, Steijlen PM. Effect of topical calcipotriol on congenital ichthyoses. Br J Dermatol 1994; 131: 546-50.
Koeger AC, Rozenberg S, Fautrel B. Effectiveness of topical calcipotriol for localized scleroderma. J Rheumatol 1999; 26: 239-40.
Gniadecki R. Calcipotriol for erythema annulare centrifugum. Br J Dermatol 2001; 146: 317-9.
Kreuter A, Gambichler T, Sauermann K et al. Extragenital lichen sclerosus successfully treated with topical calcipotriol: evaluation by in vivo confocal laser scanning microscopy. Br J Dermatol 2002; 146: 332-3.
Wong SS, Goh CL. Double-blind, right/left comparison of calcipotriol ointment and betamethasone ointment in the treatment of prurigo nodularis. Arch Dermatol 2000; 136: 807-8.
Basak PY, Ergin S. Comparative effects of calcipotriol and betamethasone 17-valerate solution in the treatment of seborrhoeic dermatitis of the scalp. J Eur Acad Dermatol Venereol 2001; 15: 86-8.
Khoo BP, Tay YK, Goh CL. Calcipotriol ointment vs. betamethasone 17-valerate ointment in the treatment of lichen amyloidosis. Int J Dermatol 1999; 38: 539-41.
Van de Kerkhof PCM, Steijlen PM. Topical treatment of pityriasis rubra pilaris with calcipotriol. Br J Dermatol 1994; 130: 675-8.
Lucker GP, Van de Kerkhof PC, Steijlen PM. Topical calcipotriol in the treatment of epidermolytic palmoplantar keratoderma of vorner. Br J Dermatol 1994; 130: 543-5.
Bogenrieder T, Landthaler M, Stolz W. Bullous congenital ichthyosiform erythroderma: safe and effective topical treatment with calcipotriol ointment in a child. Acta Derm Venereol 2003; 83: 52-4.
Godic A, Dragos V. Successful treatment of Netherton’s syndrome with topical calcipotriol. Eur J Dermatol 2004; 14: 115-7.
Fernandez-Vozmediano JM, Armario-Hita JC, Gonzalez-Cabrerizo A. Sjogren-Larsson syndrome: treatment with topical calcipotriol. Pediatr Dermatol 2003; 20: 179-80.
Harrison PV, Stollery N. Disseminated superficial actinic porokeratosis responding to calcipotriol. Clin Exp Dermatol 1994; 19: 95.
Simonart T, Peny MO, Noel JC, Dobbeler GD. Topical calcipotriol in the treatment of Darier’s disease. Eur J Dermatol 1996; 6: 36-8.
Lee IW, Ahn SK, Choi EH. Inflammatory linear verrucous epidermal nevus arising on a burn scar. Acta Derm Venereol 1999; 79: 164-5.
Metze D, Lubke D, Luger T. Hyperkeratosis lenticularis perstans (Flegel’s disease) – a complex disorder of epidermal differentiation with good response to a synthetic vitamin D3 derivative. Hautarzt 2000; 51: 31-5.
Lee HW, Chang SE, Lee MW et al. Hyperkeratosis of nipple associated with acanthosis nigricans: treatment with topical calcipotriol. J Am Acad Dermatol 2002; 46: 131-3.
Miljkovic J, Marko PB. Grover’s disease: successful treatment with acitretin and calcipotriol. Wien Klin Wochenschr 2004; 116: 81-3.
Bayramgurler D, Apaydin R, Bilen N, Muezzinoglu B. Confluent and reticulate papillomatosis: response to topical calcipotriol. J Dermatol Treat 2000; 11: 109-11.
Mizuno Y, Suga Y, Hasegawa T et al. A case of peeling skin syndrome successfully treated with topical calcipotriol. J Dermatol 2006; 33: 430-2.
Labandeira J, Vazquez-Blanco M, Paredes C et al. Efficacy of topical calcipotriol in the treatment of a giant viral wart. Pediatr Dermatol 2005; 22: 375-6.
Theng CT, Tan SH, Goh CL et al. A randomized controlled trial to compare calcipotriol with betamethasone valerate for the treatment of cutaneous lichen planus. J Dermatol Treat 2004; 15: 141-5.
Smith JV, Cox S, Blokx WA, Van de Kerhof PC et al. Actinic keratosis in renal transplant recipients do not improve with calcipotriol cream and all-trans retinoic acid cream as monotherapies or in combination during a 6-week treatment period. Br J Dermatol 2002; 147: 816-8.
Femiano F, Gombos F, Scully C et al. Oral leukoplakia: open trial of topical therapy with calcipotriol compared with tretinoin. Int J Oral Maxillofac Surg 2001; 30: 402-6.
Bower M, Colston KW, Stein RC et al. Topical calcipotriol treatment in advanced breast cancer. Lancet 1991; 337: 701-2.
Osborne JE, Hutchinson PE. The importance of accurate dosage of topical agents: a method of estimating involved area and application to calcipotriol treatment failures. J Eur Acad Dermatol Venereol 2002; 16: 367-73.
Yalsin B, Sahin S, Bukulmez G et al. Experience with calcipotriol as adjunctive treatment for vitiligo in patients who do not respond to PUVA alone: A preliminary study. J Am Acad Dermatol 2001; 44: 634-7.
Park YK, Lee JH, Chung WG. Allergic contact dermatitis from calcipotriol. Acta Derm Venereol 2002; 82: 71-2.
Kawahara C, Okada Y, Tanikawa T et al. Severe hypercalcemia and hypernatremia associated with calcipotriol for the treatment of psoriasis. J Bone Miner Metab 2004; 22: 159-62.
Hoeck HC, Laurberg G, Laurberg P. Hypercalcemic crisis after excessive topical use of a vitamin D derivative. J Int Med 1994; 235: 281-2.
Lebwohl M, Hecker D, Martinz J et al. Interactions between calcipotriene and ultraviolet light. J Am Acad Dermatol 1997; 37: 93-5.
